UNSPSC 51313500: Antihistamine or H1 blockers, synthesized

This classification denotes Antihistamine or H1 blockers composed of multiple constituents, with no dominant constituent.

UNSPSC 51313500 Antihistamine or H1 blockers, synthesized is a Class code that does not align with the recent state and local contract opportunities posted under it. The three recent solicitations—Seminole County's procurement of naloxone and drug deactivation systems, Texas Health and Human Services Commission's Request for Information on direct-to-manufacturer prescription programs, and Minnesota MMCAP's multi-state cooperative purchasing RFP for generic pharmaceuticals and OTC products—involve naloxone (an opioid antagonist), pharmacy benefit management, and broad-spectrum generic pharmaceuticals respectively. None of these opportunities centers on antihistamine H1 blockers or antihistamine procurement at the commodity level. The code assignment appears to reflect a taxonomy mismatch rather than actual buying patterns. State and local governments posting under this code do not presently show purchasing activity for antihistamine or H1 blocker products as a distinct line item.

The geographic spread of opportunities shows activity across Florida, Texas, and Minnesota, with MMCAP's cooperative purchasing vehicle extending service to Oregon and other participating jurisdictions. Issuing bodies include a county health authority (Seminole County), a state health and human services department (Texas HHS Commission), and a multi-state cooperative purchasing administration (Minnesota Department of Administration). However, these opportunities are not representative of antihistamine procurement; rather, they indicate misclassification or inconsistent code assignment by the posting agencies. No recent state or local RFP, RFQ, IFB, or ITB has specifically solicited antihistamine or H1 blocker products as named in the code's scope, suggesting minimal or no current market activity under this classification at the state and local level.